Form 4: Teradyne Director Sells Shares Under 10b5-1 Plan

Teradyne Director Mercedes Johnson sold 625 shares of common stock for $177.05 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Mercedes Johnson, a Director of Teradyne, Inc. (TER), reported a sale of common stock.
• On November 5, 2025, 625 shares of Teradyne common stock were sold at a price of $177.05 per share.
• The transaction was executed pursuant to a Rule 10b5-1 sales plan adopted by Ms. Johnson on February 3, 2025.
• Following the transaction, Ms. Johnson directly beneficially owns 9,488 shares and indirectly owns 1,876 shares through The Mercedes Johnson Trust UAD 07/23/04.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can be perceived negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns that it's based on new, adverse material information. It's a routine, scheduled transaction.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating a scheduled transaction rather than a discretionary sale based on new material information.

Negatives

• A director selling shares, even under a 10b5-1 plan, reduces their direct ownership in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports an individual director's stock transaction and does not provide information relevant to broader industry trends or competitive analysis for Teradyne, Inc.

Comparison to Industry Standards

• This filing is specific to an insider transaction and does not provide data for comparison to global benchmarks, comparable companies, projects, or results.

Related Party Transactions

• The indirect beneficial ownership of 1,876 shares is held by The Mercedes Johnson Trust UAD 07/23/04, of which the Reporting Person is the trustee and sole beneficiary, representing a related party arrangement for shareholding.

Stakeholder Impact

• Shareholders: The sale of a small number of shares by a director under a 10b5-1 plan is unlikely to have a significant direct impact on other shareholders, though some may interpret it as a slight reduction in insider confidence.
• Employees, Customers, Suppliers, Creditors: This filing has no direct impact on these stakeholders.

Key Dates

Recommendation

The filing reports a routine insider sale under a pre-arranged 10b5-1 plan, which is a common practice for corporate insiders for personal financial planning. This type of transaction typically does not signal a change in the company's fundamentals or management's outlook, thus it does not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Teradyne, TER, Mercedes Johnson, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Director Transaction, Equity Sales